Lisa Monteggia
Vanderbilt Brain Institute (VBI)
Department of Pharmacology
Dr. Monteggia’s work focuses on the molecular and cellular basis of neural plasticity as it pertains to neuropsychiatric disorders. Her research seeks to elucidate the mechanisms underlying antidepressant efficacy and depression. She has also been investigating the role of Methyl-CpG-binding protein 2 (MeCP2), the gene linked to the autism spectrum disorder, Rett syndrome, in CNS function .
Dr. Monteggia’s work focuses on the molecular and cellular basis of neural plasticity as it pertains to neuropsychiatric disorders. Her research seeks to elucidate the mechanisms underlying antidepressant efficacy and depression. She has also been investigating the role of Methyl-CpG-binding protein 2 (MeCP2), the gene linked to the autism spectrum disorder, Rett syndrome, in CNS function .
Keywords: Antidepressant , Depression , growth factors , Autism , Neurodevelopmental Disorders , synaptic plasticity
Research Area: Gene Regulation , Neurodegeneration and Neuroinflamation , Developmental Neuroscience , Synaptic Function and Neuroendocrinology